Literature DB >> 8600044

Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.

H Niikura1, H Sasano, K Kaga, S Sato, A Yajima.   

Abstract

The biological significance of epidermal growth factor (EGF)-related proteins in the development and progression of endometrioid endometrial carcinoma was studied. Expression of EGF-related proteins including EGF, transforming growth factor-alpha (TGF-alpha), cripto (CR), amphiregulin (AR), and EGF receptor (EGFR) were immunohistochemically examined. Results were then correlated with clinicopathologic findings and steroid receptor status in 12 specimens with normal endometrium, 13 with endometrial hyperplasia, and 40 with endometrioid endometrial carcinoma. EGFR, EGF, TGF-alpha, and CR immunoreactivities were observed in 58.3%, 66.7%, 91.6%, and 66.7% of normal endometrial specimens; 100%, 15.4%, 100%, and 30.8% of endometrial hyperplasia specimens; and 67.5%, 32.5%, 65.0%, and 65.0% of endometrial carcinoma specimens, respectively. AR immunoreactivity was not observed in any of the normal, hyperplastic, or neoplastic endometrium. The presence or absence of EGFR or TGF-alpha in endometrial carcinoma correlated with surgical stage, depth of myometrial invasion, and findings from peritoneal washing cytology. EGF expression significantly correlated with the age of the patients and that of CR with surgical stage and peritoneal washing cytological findings. There was a significant correlation between EGFR and TGF-alpha expression, and between EGF and TGF-alpha. Co-expression of EGFR and TGF-alpha, EGFR and CR, and TGF-alpha and CR in carcinoma specimens significantly correlated with advanced surgical stage, deeper myometrial invasion, and positive peritoneal washing cytology. In normal as well as hyperplastic endometrium, endometrial glands immunohistochemically positive for TGF-alpha were generally positive for ER, but in poorly differentiated endometrial carcinoma, cells positive for TGF-alpha tended to be negative for ER. The results of the present study show that among EGF-related proteins, expression of TGF-alpha and CR seem to be associated with the progression of human endometrioid endometrial carcinoma. Additionally, expression of TGF-alpha became increasingly estrogen independent with increasing histological carcinoma grades.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600044     DOI: 10.1016/s0046-8177(96)90070-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha.

Authors:  Katya Chobotova; Mary-Elizabeth Muchmore; Janet Carver; Hyung-J Yoo; Sanjiv Manek; William J Gullick; David H Barlow; Helen J Mardon
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  The profile of the epidermal growth factor system in rat endometrium during postpartum involution period.

Authors:  Emel Alan; Narin Liman; Hakan Sağsöz
Journal:  Vet Res Commun       Date:  2015-03-11       Impact factor: 2.459

Review 3.  Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Authors:  Maria C Rangel; Hideaki Karasawa; Nadia P Castro; Tadahiro Nagaoka; David S Salomon; Caterina Bianco
Journal:  Am J Pathol       Date:  2012-04-26       Impact factor: 4.307

4.  Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.

Authors:  C Uzan; E Darai; A Valent; O Graesslin; A Cortez; R Rouzier; P Vielh
Journal:  Virchows Arch       Date:  2009-03-18       Impact factor: 4.064

Review 5.  Promising novel therapies for the treatment of endometrial cancer.

Authors:  Paola A Gehrig; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

6.  Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.

Authors:  E Sivridis; A Giatromanolaki
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner.

Authors:  Jason Gertz; Timothy E Reddy; Katherine E Varley; Michael J Garabedian; Richard M Myers
Journal:  Genome Res       Date:  2012-09-26       Impact factor: 9.043

Review 8.  Recent Advances in Endometrial Cancer.

Authors:  Arthur-Quan Tran; Paola Gehrig
Journal:  F1000Res       Date:  2017-01-27

9.  Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.

Authors:  V Janša; T Klančič; M Pušić; M Klein; E Vrtačnik Bokal; H Ban Frangež; T Lanišnik Rižner
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

Review 10.  New therapies for advanced, recurrent, and metastatic endometrial cancers.

Authors:  Vicky Makker; Angela K Green; Robert M Wenham; David Mutch; Brittany Davidson; David Scott Miller
Journal:  Gynecol Oncol Res Pract       Date:  2017-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.